Marksans Pharma Limited
MARKSANS
Rank in Stocks
#7027
Marksans Pharma Limited, along with its subsidiaries, operates internationally,... Marksans Pharma Limited, along with its subsidiaries, operates internationally, engaging in the full spectrum of generic pharmaceutical formulation activities, from research and development and manufacturing to marketing, distribution, and sales. The company's extensive product portfolio addresses a wide array of medical needs across numerous therapeutic categories. These include pain management (analgesics), conditions such as benign prostatic hyperplasia and various forms of diabetes, neurological disorders like epilepsy, anti-inflammatory conditions, hyperparathyroidism, and gastrointestinal issues like those requiring antacids or treatments for gastroenterology. Marksans Pharma also develops solutions for cardiovascular health, hormonal imbalances, oncology, gynecology, and hypertension, alongside producing antibiotics, antifungals, antiulceratives, vitamins, dermatological preparations, cephalosporins, injectables, anti-allergy, and antibacterial medications. Furthermore, the firm offers contract research and manufacturing services. Established in 1992, its corporate headquarters are situated in Mumbai, India.
Share Price
$3.29
Last synced: 2026-11-09
Market Cap
$1.49B
Change (1 day)
2.22%
Change (1 year)
47.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Marksans Pharma Limited (MARKSANS)
Category
Healthcare
Dividend history for Marksans Pharma Limited (MARKSANS)
Marksans Pharma Limited (stock symbol: MARKSANS) made a total of 13 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.05
Dividend yield (TTM) : 0.29%
The sum of all dividends (adjusted for stock splits) is : $0.05
Dividend yield (TTM) : 0.29%
Dividend payments for Marksans Pharma Limited (MARKSANS) from 2014 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.0095 | 3.81% |
| 2025 | $0.0092 | 28.13% |
| 2024 | $0.0072 | 18.36% |
| 2023 | $0.0061 | 93.48% |
| 2022 | $0.0031 | -8.11% |
| 2021 | $0.0034 | 150.29% |
| 2020 | $0.0014 | 95.12% |
| 2019 | $0.0007 | 0.87% |
| 2018 | $0.0007 | -11.18% |
| 2017 | $0.0008 | -56.83% |
| 2016 | $0.0018 | -0.77% |
| 2015 | $0.0018 | 10.40% |
| 2014 | $0.0016 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.0095 | 3.81% |
| 2025 | $0.0092 | 28.13% |
| 2024 | $0.0072 | 18.36% |
| 2023 | $0.0061 | 93.48% |
| 2022 | $0.0031 | -8.11% |
| 2021 | $0.0034 | 150.29% |
| 2020 | $0.0014 | 95.12% |
| 2019 | $0.0007 | 0.87% |
| 2018 | $0.0007 | -11.18% |
| 2017 | $0.0008 | -56.83% |
| 2016 | $0.0018 | -0.77% |
| 2015 | $0.0018 | 10.40% |
| 2014 | $0.0016 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 218.00% |
US
|
|
| 228.00% |
US
|
|
| 57.00% |
US
|
|
| 225.00% |
US
|
|
| 34.00% |
CH
|
Questions about Marksans Pharma Limited's dividend per share
What is Marksans Pharma Limited's dividend per share?
Marksans Pharma Limited's dividend per share over the last twelve months is $0.01, as of Aug 2026.
What was Marksans Pharma Limited's dividend per share in 2025?
In 2025, Marksans Pharma Limited's dividend per share was $0.01, 28.13% more than in 2024 ($0.01).
How has Marksans Pharma Limited's dividend per share changed since 2020?
From 2020 to 2025, Marksans Pharma Limited's dividend per share went from $0.00 to $0.01, an average growth of 46.50% a year.